MedWatch Safety Alert Email Service Customer Satisfaction Survey

MedWatch Customer Satisfaction Survey
1. FDA MedWatch Customer Satisfaction Survey
Your participation/non-participation is completely voluntary and your responses will not effect your
eligibility to receive any FDA services. All respondent identification and information are anonymous.

2. Demographics
Which of the following best describes your primary status as a healthcare
professional/student? (Choose one)
c
d
e
f
g

Physician

c
d
e
f
g

Pharmacist/Pharmacy technician

c
d
e
f
g

Dentist/Dental Specialist/Dental hygienist

c
d
e
f
g

Nurse/Nurse Practitioner

c
d
e
f
g

Physician Assistant

c
d
e
f
g

Medical resident or fellow

c
d
e
f
g

Medical, pharmacy, nursing, or allied health professional student

c
d
e
f
g

Medical Informatics/librarian in health system setting

c
d
e
f
g

Medical Information media provider/reporter

c
d
e
f
g

Consumer (not a healthcare professional/student)

c
d
e
f
g

Other (please specify)

Selected Responses
will Prompt Responder
to Section 7 "Thank
you for taking the time
to complete the
survey"

MedWatch Customer Satisfaction Survey
Which of the following best describes your primary work setting? (Choose
one)
j
k
l
m
n

Department of Defense (DoD) or Veteran's Affairs (VA)

j
k
l
m
n

Other government agency

j
k
l
m
n

Private practice; self-employed

j
k
l
m
n

Community-based small group (less than 5 practitioners)

j
k
l
m
n

Multi-specialty group practice, Health Maintenance Organization (HMO)

j
k
l
m
n

Academic medical center

j
k
l
m
n

Community Hospital

j
k
l
m
n

Academia

j
k
l
m
n

Pharmaceutical, device, or biological industry

j
k
l
m
n

Retail Pharmacy

j
k
l
m
n

Investment firm

j
k
l
m
n

News Media

j
k
l
m
n

Other (please specify)

Selected Responses
will Prompt Responder
to Section 7 "Thank
you for taking the time
to complete the
survey"

3. Customer Satisfaction with MedWatch Safety Alert Email

MedWatch Customer Satisfaction Survey
How satisfied are you with each of the following elements of the MedWatch
Safety Alert emails?
Satisfied
a. Adequacy of the
details provided in the

Neither Satisfied/Nor
Dissatisfied

Dissatisfied

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

c
d
e
f
g

subject line of emails
b. Identification of the
intended audience
c. Appropriate length
of emails
d. Ease of reading the
email content
e. Clinical relevance of
the information to me
f. Provision of enough
information for me to
take action (if
necessary)
g. Useful
supplemental links
provided in the email
h. Please recommend improvements or provide additional clarification to your responses.

How do you use the MedWatch Safety Alert email information you receive?
(Check all that apply)
c
d
e
f
g

a. To stay current on medical product safety

c
d
e
f
g

b. To inform other colleagues in my work group

c
d
e
f
g

c. To present new information at my committee meetings

c
d
e
f
g

d. To publish the information in professional newsletters

c
d
e
f
g

e. To add content to my organization's Web site

c
d
e
f
g

f. To update drug information in my organization's electronic formulary or Electronic Medical Record (EMR)

c
d
e
f
g

g. Other (please specify)

MedWatch Customer Satisfaction Survey
On average, with how many individuals in your organization do you share
MedWatch Safety Alert emails information?
j
k
l
m
n

0

j
k
l
m
n

1-9

j
k
l
m
n

10-24

j
k
l
m
n

25-99

j
k
l
m
n

100-499

j
k
l
m
n

500+

4. Targeting Messages
At this time, all MedWatch Safety Alert emails are sent to all who subscribe to the MedWtach listserv.
FDA is considering whether it should target email distribution and wants your feedback about how best
to do this.

If you could choose to receive product-specific MedWatch Safety Alert
emails only, for which groups of products would you want to receive only
that information? (Check all that apply)
c
d
e
f
g

a. Drugs and Biologics (prescription and over-the-counter)

c
d
e
f
g

b. Medical devices (e.g., stents, implants, radiological products, diagnostics)

c
d
e
f
g

c. Blood, blood products and tissue

c
d
e
f
g

d. Vaccines

c
d
e
f
g

e. Dietary supplements

c
d
e
f
g

f. Food allergens

c
d
e
f
g

g. Food-related outbreaks

c
d
e
f
g

h. Cosmetics

c
d
e
f
g

Other (please specify)

MedWatch Customer Satisfaction Survey
If you could choose to receive MedWatch Safety Alert emails with specific
information only, which of the following types of information would you
want to receive? (Check all that apply)
c
d
e
f
g

a. Emerging safety information about human medical products

c
d
e
f
g

b. Labeling changes with associated "Dear Healthcare Professional" letter issued by manufacturer

c
d
e
f
g

c. Recalls of drugs with a potential for serious injury/death

c
d
e
f
g

d. Recalls of medical devices with a potential for serious injury or death

c
d
e
f
g

e. Notices of safety issues related to off label or inappropriate use of drugs or devices

c
d
e
f
g

f. Safety information about newly approved drugs

c
d
e
f
g

Other (please specify)

If you could choose to receive MedWatch Safety Alert emails applicable to
specific audiences only, for which audience would you want to receive that
information? (Check all that apply)
c
d
e
f
g

General health professionals (e.g., Pharmacists, Nurses, Physicians)

c
d
e
f
g

Medical specialty audiences (e.g., urology, oncology)

c
d
e
f
g

General Public

c
d
e
f
g

Other (please specify)

5. Monthly Drug Safety Labeling Changes
The following questions pertain to the MedWatch webposting/emails about Monthly Drug Safety Labeling
Changes.

MedWatch Customer Satisfaction Survey
How do you use the MedWatch information about Monthly Drug Safety
Labeling Changes? (Check all that apply)
c
d
e
f
g

a. To stay current on medical product safety

c
d
e
f
g

b. To inform other colleagues in my work group

c
d
e
f
g

c. To present new information at my committee meetings

c
d
e
f
g

d. To publish the information in professional newsletters

c
d
e
f
g

e. To add content to my organization's Web site

c
d
e
f
g

f. To update drug information in my organization's electronic formulary or Electronic Medical Record (EMR)

c
d
e
f
g

g. Other (please specify)

On average, with how many individuals in your organization do you share
MedWatch information about Monthly Drug Safety Labeling Changes?
j
k
l
m
n

0

j
k
l
m
n

1-9

j
k
l
m
n

10-24

j
k
l
m
n

25-99

j
k
l
m
n

100-499

j
k
l
m
n

500+

Please recommend improvements FDA could make in its MedWatch
information about Monthly Drug Safety Labeling Changes.
5
6

6. Social Media

MedWatch Customer Satisfaction Survey
How else would you like to receive MedWatch Safety Alert emails or
MedWatch information about Monthly Drug Safety Labeling Changes?
(Check all that apply)
c
d
e
f
g

Text messaging

c
d
e
f
g

Audio (i.e. Podcast)

c
d
e
f
g

Video (i.e. YouTube)

c
d
e
f
g

Blogs

c
d
e
f
g

Facebook

c
d
e
f
g

Twitter

c
d
e
f
g

MySpace

c
d
e
f
g

GoogleWave

c
d
e
f
g

LinkedIn

c
d
e
f
g

Other (please specify)

7. Thank you for taking the time to complete and submit this survey
Please provide any comments regarding the MedWatch program in the
space provided. Please do not supply any personal information. Your
feedback is useful and appreciated.
5
6